Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension

T. Satoh, K. Kimura, Y. Okano, M. Hirakata, Y. Kawakami, M. Kuwana

Research output: Contribution to journalArticle

8 Citations (Scopus)


Objectives. To examine whether autoantibodies against bone morphogenetic protein receptor-II (BMPR-II) or activin receptor-like kinase 1 (ALK-1) are associated with pulmonary arterial hypertension (PAH) in patients with mixed connective tissue disease (MCTD). Methods. We studied sera from 37 MCTD patients with or without PAH, six patients with idiopathic PAH, and 30 healthy controls. Circulating anti-BMPR-II and anti-ALK-1 antibodies were detected using immunoprecipitation of recombinant antigens generated by in vitro transcription/translation and indirect immunofluorescence of cultured cells that were induced to express these antigens by gene transfer. Anti-BMPR-II antibodies were further examined by immunoprecipitation and immunoblotting using a recombinant fragment of the extracellular domain of BMPR-II. Results. Serum anti-BMPR-II and anti-ALK-1 autoantibodies were not detected in MCTD patients irrespective of the presence or absence of PAH, or in patients with idiopathic PAH. Conclusions. Our finding does not support the hypothesis that autoantibody-mediated dysregulation of signals through BMPR-II or ALK-1 contributes to the development of PAH in patients with connective tissue diseases.

Original languageEnglish
Pages (from-to)192-196
Number of pages5
Issue number2
Publication statusPublished - 2005 Feb 1



  • Activin receptor-like kinase 1
  • Autoantibody
  • Bone morphogenetic protein receptor-II
  • Mixed connective tissue disease
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this